ea0020p561 | Neuroendocrinology, Pituitary and Behaviour | ECE2009
Colao Annamaria
, Auriemma Renata S
, Savastano Silvia
, Galdiero Mariano
, Grasso Ludovica FS
, Lombardi Gaetano
, Pivonello Rosario
Objective: The impact of first-line somatostatin analogues (SSA) on glucose tolerance in acromegaly was investigated during a 10 year period.Patients: One hundred and twelve patients treated with depot SSA.Outcome measures: Primary outcome measures were fasting glucose levels. Data were analyzed according with baseline glucose tolerance and disease control.Results after 12 months SSA treatment: In the 63 pati...